Apixaban and Omega-3
Supplement–drug interaction evidence from the TruthStack database.
| Severity | HIGH |
|---|---|
| Evidence Tier | Moderate |
| Interaction Type | BLEEDING RISK |
| Mechanism | PHARMACODYNAMIC |
| Last Reviewed | 2026-02-15 |
Summary
High-dose fish oil has antiplatelet and anticoagulant effects. Combining with apixaban may increase bleeding risk. Monitor for bruising and bleeding at doses above 3g/day. Discuss with your prescriber or pharmacist.
Higher-Concern Contexts
This interaction may be of particular concern in the following contexts:
- anticoagulant use
CYP Enzyme Profiles
Published CYP enzyme data for compounds in this interaction:
Apixaban: CYP3A4 substrate (moderate), P-gp substrate (moderate)
Shared Pharmacodynamic Endpoints
Both compounds influence the same physiological endpoints in the same direction:
| Endpoint | Direction | Apixaban | Omega-3 |
|---|---|---|---|
| COAGULATION | DECREASE | STRONG | WEAK |
Cumulative effect on shared endpoints may exceed individual compound profiles. This is relevant to discussion with a prescribing clinician.
API Reference
Open, unauthenticated. Returns JSON. Developer documentation